NCT00360334 A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00359879 Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00359762 Exenatide Versus Glimepiride in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00358436 Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD) Status COMPLETED Phase PHASE3
NCT00358280 Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery Status COMPLETED Phase PHASE3
NCT00357682 A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia Status COMPLETED Phase PHASE3
NCT00357370 A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2/PHASE3
NCT00357110 Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT00352469 Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety Status COMPLETED Phase PHASE4
NCT00352261 An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients Status COMPLETED Phase PHASE4
NCT00351910 Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00351169 Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00348686 Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) Status COMPLETED Phase PHASE4
NCT00347217 Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event Status COMPLETED Phase N/A
NCT00344773 First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation Status COMPLETED Phase PHASE2